Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Lasmiditan (LY573144) Over Four Migraine Attacks

ClinicalTrials.gov ID: NCT03670810

Public ClinicalTrials.gov record NCT03670810. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Controlled Trial of Lasmiditan Over Four Migraine Attacks

Study identification

NCT ID
NCT03670810
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
1,633 participants

Conditions and interventions

Conditions

Interventions

  • Lasmiditan Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 23, 2019
Primary completion
Jun 11, 2020
Completion
Jul 7, 2021
Last update posted
Jul 28, 2022

2019 – 2021

United States locations

U.S. sites
14
U.S. states
11
U.S. cities
13
Facility City State ZIP Site status
Rehabilitation & Neurological Services LLC Huntsville Alabama 35805
Barrow Neurological Institute Phoenix Arizona 85013
UCSD Altman Clinical & Translational Research Institute (ACTRI) La Jolla California 92121
Colorado Neurological Institute Englewood Colorado 80113
Georgetown University Hospital Washington D.C. District of Columbia 20007
George Washington University Medical Center Washington D.C. District of Columbia 20037
Diamond Headache Clinic Chicago Illinois 60642
Ochsner Medical Center - North Shore Covington Louisiana 70433
StudyMetrix Research, LLC City of Saint Peters Missouri 63303
Nevada Headache Institute Las Vegas Nevada 89113-2237
Dent Neurological Institute Amherst New York 14226
Island Neuro Associates,PC Plainview New York 11803
Montefiore Headache Center The Bronx New York 10461
Northwest Clinical Research Center Bellevue Washington 98007-4209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 127 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03670810, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 28, 2022 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03670810 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →